Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis, ...

The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound ...

There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of the disease to be aware of.

An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an expert.

I find strength and hope in the daffodils I grow, helping me face chronic lymphocytic leukemia with renewed determination.

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal ...

Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks.

Radiation therapy for gastrointestinal cancers is more precise and easier to tolerate due newer technologies and personalized ...

Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...